50% Off! Beat the market in 2025 with InvestingProCLAIM SALE

IMCD stock upgraded to Buy by Kepler Cheuvreux with a EUR30.50 target hike

EditorAhmed Abdulazez Abdulkadir
Published 2024-12-06, 06:44 a/m
IMCD
-

On Friday, Kepler Cheuvreux resumed coverage on IMCD NV (AS:IMCD:NA) with an optimistic outlook, upgrading the stock to a "Buy" from a previous "Hold" rating. The firm also increased the price target to €179.00, up from €148.50. According to Kepler Cheuvreux, the decision comes after a hiatus linked to IMCD's €300 million capital increase.

IMCD, recognized as a leading global distributor of specialty chemicals, has demonstrated a strong execution track record since its initial public offering in 2014. This performance is evidenced by its 19% annual Total (EPA:TTEF) Shareholder Return (TSR), which has been supported by a 19% compound annual growth rate (CAGR) in reported Earnings Per Share (EPS).

The firm's competitive edge is maintained by significant barriers to entry due to its scale advantages in a notably fragmented industry. Although IMCD experienced a phase of consolidation in organic EBITA growth, with a decrease of 7% and 3% in the expected years 2023 and 2024 respectively, and below-average shareholder returns at 3% TSR per year for the same period, Kepler Cheuvreux anticipates a positive shift.

The analyst at Kepler Cheuvreux projects that growth for IMCD will pick up pace, forecasting a 10% and 14% organic three-year EBITA and EPS CAGR, respectively. Additionally, the potential for earnings-per-share enhancing mergers and acquisitions in the short term is highlighted, with an estimated 11-18% annual EPS growth potential.

IMCD's new price target is derived from a Discounted Cash Flow (DCF) analysis that includes potential mergers and acquisitions, setting the target at 18 times the estimated 2025 Enterprise Value to EBITA (EV/EBITA). The firm's optimistic stance reflects an anticipation of favorable risk-reward dynamics, as IMCD is poised to accelerate its growth trajectory.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.